Hyperglycemia in the intensive care unit: No longer just a marker of illness severity

Surgical Infections

Volumn 6, Issue 2, 2005, Pages 233-245

  Taylor, Jodie H ^a,b   Beilman, Greg J ^a,c,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c NORTH MEMORIAL MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ANTIINFLAMMATORY ACTIVITY; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE MARKER; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFECTION RISK; INSULIN TREATMENT; INTENSIVE CARE UNIT; MEDICAL LITERATURE; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PUBLISHING; REVIEW; SURGICAL PATIENT; SURVIVAL RATE; WOUND HEALING IMPAIRMENT;

CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; SEVERITY OF ILLNESS INDEX; STRESS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 25844465324     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2005.6.233     Document Type: Review

References (79)

1. Black PR, Brooks DC, Bessey PQ, et al. Mechanisms of insulin resistance following injury. Ann Surg 1983;196:420-435.
2. Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery 2000;128:757-760.
3. Groeneveld ABJ, Beishuizen A, Visser FC. Insulin: A wonder drug in the critically ill? Crit Care 2002;6: 102-105.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
5. Agwunobi AO, Reid C, Maycock P, et al. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000;85:3770-3778.
6. Gelfand RA, Matthews DE, Bier DM, et al. Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest 1984;74:2238-2248.
7. Hrebicek A, Rypka M, Chmela Z, et al. Tumor necrosis factor-alpha in various tissues of insulin-resistant obese Koletsky rats: Relations to insulin receptor characteristics. Physiol Res 1999;48:83-86.
8. Qi C, Pekala PH. Tumor necrosis factor-α-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 2000;223:128-135.
9. Beal A, Deuser W, Beilman G. A role for epinephrine in posttraumatic hypokalemia. Shock 2003;19:5.
10. Thorell A, Nygran J, Ljungqvist O. Insulin resistance: A marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999;2:69-78.
11. Frayn KN, Little RA, Maycock PF, Stoner HB. The relationship of plasma catecholamines to acute metabolic and hormonal responses to injury in man. Circ Shock 1985;16:229-240.
12. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-360.
13. Baird TA, Parsons MW, Phahn T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcomes. Stroke 2003;34:2208-2214.
14. Yendamuri, S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003;55:33-38.
15. Lannoo E, Van Rietvelde F, Colardyn F, et al. Early predictors of mortality and morbidity after severe closed head injury. J Neurotrauma 2000;17:403-414.
16. Lam AM, Winn HR, Cullen BF, et al. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991;75:545-551.
17. Kraig RP, Petito CK, Plum F, et al. Hydrogen ions kill brain at concentrations reached in ischemia. J Cereb Blood Flow Metab 1987;7:379-386.
18. Anastassios G, Pittas MD, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients Arch Intern Med 2004;164:2005-2011.
19. Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. JPEN J Parenter Enteral Nutr 1991;15: 60-64.
20. Bagdale JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978;27:677-681.
21. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9:1-9.
22. Kwoun MO, Ling PR, Lydon E, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997;21:91-95.
23. Oldenborg PA, Sehlin J. Hyperglycemia in vitro attenuates insulin-stimulated chemokinesis in normal human neutrophils. Role of protein kinase C activation. J Leukoc Biol 1999;65:635-640.
24. Friedman SG, Pearce FJ, Drucker WR. The role of blood glucose in defense of plasma volume during hemorrhage. J Trauma 1982;22:86-91.
25. Pierce FJ, Drucker WR. Glucose infusion arrests the decompensatory phase of hemorrhagic shock. J Trauma 1987;27:1213-1220.
26. DeFronzo RA, Tobin JD, Anders R. Glucose clamp technique: A method for quantifying insulin secretion and resistance Am J Physiol Endocrinol Metab 1979; 237:E214-E223.
27. Thorell A, Efendic S, Gutniak M, et al. Insulin resistance after abdominal surgery. Br J Surg 1994;81: 59-63.
28. Lang CH, Dobrescu C, Meszaros K. Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism 1990;39:1096-1107.
29. Bell GI, Kayano T, Buse JB, et al. Molecular biology of mammalian glucose transporters. Diabetes Care 1990;13:198-208.
30. Giorgino, F, Almahfouz, A, Goodyear, LJ, et al. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 1993;91: 2020-2030.
31. Venkatesan N, Lim J, Bouch C, et al. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism 1996;45:92-100.
32. Coderre L, Srivastava AK, Chiasson JL. Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by insulin. Am J Physiol Endocrinol Metab 1992;262:E427-E433.
33. Paz K, Hemi R, LeRoith D, et al. A molecular basis for insulin resistance. J Biol Chem 1997;272:29911-29918.
34. Qi C, Pekala PH. Tumor necrosis factor-α-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 2000 223:128-135.
35. Eigler N, Sacca L, Sherwin RS. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: A model for stress-induced hyperglycemia. J Clin Invest 1979;63:114-123.
36. Takala, J, Ruokonen, E, Webster, NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-792.
37. Vary TC. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: Effects on plasma lactate. Shock 1996;6:89-94.
38. Shangraw RE, Jahoor F, Wolfe RR, et al. Pyruvate dehydrogenase inactivity is not responsible for sepsis-induced insulin resistance. Crit Care Med 1996;24: 566-574.
39. Cherrington AD, Fuchs H, Stevenson RW, et al. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs. Am J Physiol Endocrinol Metab 1984;247:E137-144.
40. Sherwin RS, Sacca L. Effect of epinephrine on glucose metabolism in humans: Contribution of the liver. Am J Physiol Endocrinol Metab 1984; 247:E157-E165.
41. Stevenson RW, Steiner KE, Connolly CC, et al. Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol Endocrinol Metab 1991;260:E363-E370.
42. Connolly CC, Steiner KE, Stevenson RW, et al. Regulation of glucose metabolism by norepinephrine in conscious dogs. Am J Physiol Endocrinol Metab 1991; 261:E764-E772.
43. McGuiness OP, Fugiwara T, Murrell S, et al. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol Endocrinol Metab 1993;265:E314-E322.
44. McGuinness OP, Snowden RT, Moran C, et al. Impact of acute epinephrine removal on hepatic glucose metabolism during stress hormone infusion. Metabolism 1999;48:910-914.
45. Herndon DN, Hart DW, Wolfe SE, et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001;345:1223-1229.
46. Bessey PQ, Brooks DC, Black PR, et al. Epinephrine acutely mediates skeletal muscle insulin resistance. Surgery 1983;94:172-179.
47. Lang CH, Frost RA. Role of growth hormone, insulin-like growth factor-1, and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care 2002; 5:271-279.
48. Jeevanandam M, Young DH, Schiller WR. Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J Trauma 1990;30:582-589.
49. Smith SR, Bai F, Charbonneau C, et al. A promotor genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003;52:1611-1618.
50. Rosak C. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents. J Diabetes Complications 2002;16:123-132.
51. Gore DC, Wolf SE, Herndon DN, et al. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 2003;54:555-561.
52. Van den Berghe G, Wouters PJ, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359-366.
53. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047.
54. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998;22:77-81.
55. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990;30:830-832.
56. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989;38: 1031-1035.
57. Rassias, AJ, Marrin, CAS, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999;88:1011-1016.
58. Rassias AJ, Givan AL, Marrin CAS, et al. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002;94:1113-1119.
59. Ortmeyer J, Mohsenin V. Glucose suppresses superoxide generation in normal neutrophils: Interference in phospholipase D activation. Am J Physiol Cell Physiol 1993;264:C402-C410.
60. Gallacher SJ, Thomson G, Fraser WD, et al. Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet Med 1995;12:916-920.
61. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998;101: 1905-1915.
62. Kjersem H, Hilsted J, Madsbad S, et al. Polymorphonuclear leukocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients. Infection 1988;16:215-221.
63. Mohanty P, Hamouda W, Garg R, et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes. J Clin Endocrinol Metab 2000; 85:2970-2973.
64. Dandona P, Alkada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001;86:3257-3265.
65. Losser M-R, Bernard C, Beaudeux J-L, et al. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997,83:1566-1574.
66. Lerman OZ, Galiano RD, Armour M, et al. Cellular dysfunction in the diabetic fibroblast: Impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003; 162:303-312.
67. Noyman I, Marikovsky M, Sasson S, et al. Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells. Nitric Oxide 2002;7:187-193.
68. Satoh H, Togo M, Hara M, et al. Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem Biophys Res Commun 1997;239: 111-115.
69. Alexiewicz JM, Kumar D, Smogorzewski M, et al. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: Abnormalities in metabolism and function. Ann Intern Med 1995;123:919-924.
70. Tobe K, Asai S, Matuoka K, et al. Cytoskeletal reorganization induced by insulin: Involvement of Grb2/Ash, Ras, and phosphatidylinositol 3-kinase signaling. Genes Cells 2003;8:29-40.
71. Zigmond SH. Signal transduction and actin filament organization. Curr Opin Cell Biol 1996;8:66-73.
72. Marfella R, Esposito K, Guinta R, et al. Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia. Circulation 2000;101:2247-2251.
73. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. Ann Surg 1992; 216:172-183.
74. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med 1991;325: 525-532.
75. Marik PE, Raghavan M. Stress-hyperglycemia, insulin, and immunomodulation in sepsis. Intensive Care Med 2004;30:748-56.
76. DIGAMI Study Group, Malmberg K, Ryden L, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): Effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
77. Dandona P, Aljada A. Dhindsa S, Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin Cornerstone 2003;S4:S13-S20.
78. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004;239:553-560.
79. Aljada A, Ghanim H, Saadeh R, Dandona P. Insulin inhibits NFκB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 2001;86: 450-453.